C. Iasella

发表

Adverse Drug Reactions: Type A (Intrinsic) or Type B (Idiosyncratic).

C. Iasella, H. Johnson, M. Dunn, 2017, Clinics in liver disease.

Triple Antithrombotic Therapy with Direct Oral Anticoagulants Versus Warfarin after Percutaneous Coronary Intervention with Genotyping

S. Kane-Gill, P. Empey, J. Coons, 2019 .

Triple Antithrombotic Therapy With Aspirin, P2Y12 Inhibitor, and Warfarin After Percutaneous Coronary Intervention

S. Kane-Gill, J. Coons, C. Iasella, 2017, Journal of cardiovascular pharmacology and therapeutics.

Lung transplantation for idiopathic pulmonary fibrosis enriches for individuals with telomere-mediated disease.

B. Methé, M. Saul, K. Gibson, 2021, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Maintenance Belatacept-Based Immunosuppression in Lung Transplantation Recipients Who Failed Calcineurin Inhibitors

C. Ensor, M. Morrell, J. McDyer, 2018, Transplantation.

Systematic review and meta‐analysis of post‐transplant lymphoproliferative disorder in lung transplant recipients

C. Ensor, M. Morrell, J. McDyer, 2018, Clinical transplantation.

Effect of Selective Serotonin Reuptake Inhibitors on Cardiovascular Outcomes After Percutaneous Coronary Intervention: A Retrospective Cohort Study

J. Coons, C. Iasella, J. Stevenson, 2019, Clinical Drug Investigation.

Type‐1 immunity and endogenous immune regulators predominate in the airway transcriptome during chronic lung allograft dysfunction

Joyce S Lee, J. Golden, W. Xu, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Belatacept for maintenance immunosuppression in cardiothoracic transplantation: The potential frontier

C. Ensor, R. Venkataramanan, M. Morrell, 2018, Clinical transplantation.

Impaired Cytomegalovirus Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres

P. Shah, J. Pilewski, Yingze Zhang, 2019, American journal of respiratory and critical care medicine.

Comparative Effectiveness and Safety Analysis of Dual Antiplatelet Therapies Within an Integrated Delivery System

Nan Wang, C. Ensor, J. Coons, 2017, The Annals of pharmacotherapy.

Effectiveness and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients with Acute Venous Thromboembolism

J. Coons, C. Iasella, Lauren Albert, 2020, Pharmacotherapy.

Idiopathic pulmonary fibrosis lung transplant recipients are at increased risk for EBV‐associated posttransplant lymphoproliferative disorder and worse survival

C. Ensor, S. Nouraie, D. Kass, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Aerosolization of second-generation triazoles: In vitro evaluation and application in therapy of invasive airway aspergillosis.

T. Corcoran, C. Ensor, R. Venkataramanan, 2019, Transplantation.

CD4+ T Cell Dysfunction in Severe COVID-19 Disease is TNFα/TNFRI-Dependent.

Bill B. Chen, M. Saul, D. Triulzi, 2022, American journal of respiratory and critical care medicine.

Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction.

J. Pilewski, C. Ensor, M. Morrell, 2020, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

CD4+ T-Cell Dysfunction in Severe COVID-19 Disease Is Tumor Necrosis Factor-α/Tumor Necrosis Factor Receptor 1–Dependent

Bill B. Chen, D. Triulzi, D. Kass, 2022, American Journal of Respiratory and Critical Care Medicine.

CD4+ T cell lymphopenia and dysfunction in severe COVID-19 disease is autocrine TNF-α/TNFRI-dependent

Bill B. Chen, M. Saul, J. Pilewski, 2021, bioRxiv.

Janus kinase inhibition for immunosuppression in solid organ transplantation: Is there a role in complex immunologic challenges?

C. Ensor, Fadi G Lakkis, R. Venkataramanan, 2017, Human immunology.

Cytokine-targeted therapy for the management of solid organ transplant recipients.

C. Ensor, J. McDyer, C. Iasella, 2019, Human immunology.

Rate of recipient‐derived alveolar macrophage development and major histocompatibility complex cross‐decoration after lung transplantation in humans

M. Myerburg, Yingze Zhang, M. Snyder, 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Clinical outcomes with unfractionated heparin monitored by anti‐factor Xa vs. activated partial Thromboplastin time

Roy E. Smith, Neal J. Benedict, C. Iasella, 2019, American journal of hematology.

Transcriptome Analysis of Airway Brushes in Lung Transplant Recipients with and without Chronic Lung Allograft Dysfunction.

J. Greenland, M. Snyder, M. Morrell, 2020, The Journal of Heart and Lung Transplantation.

Airway Transcriptome Analysis and Immune Proteome Profiling of the Lung Allograft Reveals Novel Immune Signatures in Chronic Lung Allograft Dysfunction

J. Pilewski, Yingze Zhang, Kong Chen, 2019, The Journal of Heart and Lung Transplantation.

Increasing tacrolimus time‐in‐therapeutic range is associated with superior one‐year outcomes in lung transplant recipients

C. Ensor, R. Venkataramanan, M. Morrell, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Risk factors of bronchial dehiscence after primary lung transplantation

J. Pilewski, E. Chan, R. Rivosecchi, 2022, Journal of cardiac surgery.

Impaired CMV Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres.

P. Shah, J. Pilewski, Yingze Zhang, 2018 .

Effectiveness and Safety of Direct Oral Anticoagulants versus Warfarin in Lung Transplant Recipients

R. Rivosecchi, M. Morrell, J. McDyer, 2021 .

A Pharmacotherapy Scholars Program to Provide Intensive Training to Enhance Pharmacy Students’ Postgraduate Readiness

Amy L. Seybert, M. Saul, C. Ensor, 2019, American Journal of Pharmaceutical Education.

Evaluating the Effects of a Medication Adherence Packaging Program on Outcomes in Older People.

C. Ruby, C. Iasella, Monica B Aspinall, 2022, The Senior care pharmacist.

Cross-Regulation of F-Box Protein FBXL2 with T-bet and TNF-α during Acute and Chronic Lung Allograft Rejection

Bill B. Chen, R. Mallampalli, S. Frizzell, 2022, The Journal of Immunology.

Lung transplant recipients with telomere-mediated pulmonary fibrosis have increased risk for hematologic complications.

Yingze Zhang, R. Farah, A. Im, 2023, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

DOAC Dosing Discordance Using Different Estimates of Kidney Function and Outcomes

C. Iasella, James C. Coons, Jesse Cheng, 2023, Journal of clinical pharmacology.

Impact of age and telomere length on circulating T cells and rejection risk after lung transplantation for idiopathic pulmonary fibrosis.

Yingze Zhang, M. Snyder, Andrew Craig, 2023, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Rabbit Antithymocyte Globulin for Treatment of Corticosteroid Refractory Acute Cellular Rejection After Lung Transplantation

R. Rivosecchi, M. Snyder, J. McDyer, 2023, Transplantation.

Incidence of Acute Cellular Rejection After Granulocyte Colony-Stimulating Factor in Lung Transplant Recipients.

R. Rivosecchi, M. Snyder, M. Morrell, 2023, Journal of pharmacy practice.

Chronic Lung Allograft Dysfunction is Associated with an Increased Number of Non-HLA Antibodies.

G. Westall, J. Taupin, C. Iasella, 2023, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.